Fresenius Medical Care AG (FMS) Net Income towards Common Stockholders (2009 - 2025)

Fresenius Medical Care AG's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at $68.7 million for Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders rose 104.67% year-over-year to $68.7 million; the TTM figure through Dec 2025 stood at -$2.8 billion (up 40.77% YoY), while the FY2025 annual figure was $1.1 billion, up 98.13% from the prior year.
• Net Income towards Common Stockholders was $68.7 million for Q4 2025 at Fresenius Medical Care AG, up from -$739.2 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $176.2 million in Q1 2022 to a low of -$1.6 billion in Q4 2022.
• Historically, Net Income towards Common Stockholders has averaged -$999.6 million across 5 years, with a median of -$1.1 billion in 2021.
• The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders soared 116.27% in 2022, then slumped 1402.42% in 2024.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$1.4 billion in 2021, then dropped by 10.86% to -$1.6 billion in 2022, then soared by 36.32% to -$1.0 billion in 2023, then sank by 43.99% to -$1.5 billion in 2024, then soared by 104.67% to $68.7 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at $68.7 million (Q4 2025), -$739.2 million (Q3 2025), and -$1.2 billion (Q2 2025), per Business Quant data.